Patent=WO2009156155A1
Volker Sandig, Ingo Jordan;
Cell line for propagation of highly attenuated alphaviruses.
Patent number WO2009156155A1, 30-Dec-2009

PubMed=19071186; DOI=10.1016/j.vaccine.2008.11.066
Ingo Jordan, Ad Vos, Stefanie Beilfuss, Andreas Neubert, Sabine Breul, Volker Sandig;
An avian cell line designed for production of highly attenuated viruses.
Vaccine 27:748-756(2009)

PubMed=19531390; DOI=10.1016/j.vaccine.2009.05.083
Verena Lohr, Alexander Rath, Yvonne Genzel, Ingo Jordan, Volker Sandig, Udo Reichl;
New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation.
Vaccine 27:4975-4982(2009)

DOI=10.17169/refubium-4684
Christiane Ogorek;
Characterization of the N-glycosylation profile of the new avian cell line AGE1.CR and the modification of fucosylation.
Thesis PhD (2012); Freien Universitat Berlin; Berlin; Germany

PubMed=25903999; DOI=10.1002/biot.201400388
Yvonne Genzel;
Designing cell lines for viral vaccine production: where do we stand?
Biotechnol. J. 10:728-740(2015)

PubMed=26814192; DOI=10.1080/03079457.2016.1138280
Ingo Jordan, Katrin John, Kristin Howing, Verena Lohr, Zoltan Penzes, Erzsebet Gubucz-Sombor, Yan Fu, Peng Gao, Timm Harder, Zoltan Zadori, Volker Sandig;
Continuous cell lines from the Muscovy duck as potential replacement for primary cells in the production of avian vaccines.
Avian Pathol. 45:137-155(2016)